prohibited list raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-12-03 and is reviewed periodically as new material appears.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
| Property | Value | Notes |
|---|---|---|
| Primary target | PPARδ (NR1C2) | Nuclear receptor involved in lipid metabolism |
| Preclinical effect | Increased fatty acid oxidation | Observed in rodent studies |
| Key safety signal | Tumors in rodents after long-term exposure | Contributed to halted clinical development |
| Human trial status | No approved product; development stopped | Limited short-term metabolic data |
| Sport regulatory status | Prohibited at all times | WADA hormone and metabolic modulators class |
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
Bukele has threatened incarcerated gang members. At the beginning of the crackdown, he tweeted that the government had seized incarcerated gang members' belongings, removed their mattresses, and rationed their food. Bukele also posted a video of prisoners sleeping on floors and complaining about a lack of food and sanitation. He threatened to deprive them of food entirely in April 2022 if the gangs attempted to retaliate against the crackdown, citing rumors about revenge killings. After members of Barrio 18 killed three police officers in Santa Ana in June 2022, Bukele said at a press conference that the gangs were "going to pay dearly" for the "ambush" against the police. The government began destroying gravestones belonging to deceased gang members in November 2022 to prevent them from becoming "shrines" and Bukele compared the gravestone destructions to denazification in post-World War II Germany. He warned Salvadoran parents to keep their children away from gangs, since they would lead to "prison or death". Shortly after the crackdown began, Bukele called for the construction of a new 20,000-inmate prison. He announced the construction in July 2022 of the 40,000-inmate Terrorism Confinement Center (CECOT) in Tecoluca, that would be one of the world's largest prisons. In February 2023, Bukele posted a video on Twitter of him and members of his cabinet touring the prison. It is staffed by 250 police officers and 600 soldiers, and covers 410 acres (170 ha).
Israel airstrikes struck Khiam, Zebqin, Yater, Shebaa, Nabatieh, Bir Kalb, Kfar Kila, Aalma ech Chaab, and Mays al-Jabal, killing a Hezbollah militant and a Amal Movement militant. Another three people were wounded, namely a Hezbollah militant and a Syrian national. An Israeli Navy officer was killed by a malfunctioning missile launched by the Iron Dome on a Dvora-class fast patrol boat off the coast of Nahariya, northern Israel and two others were injured. An Israel drone strike struck Zawtar El Charkiyeh. The Amal movement said one of its fighters from Khiam was killed. Hezbollah confirmed the death of six militants. Departures and arrivals were canceled at Ben Gurion Airport until 10 a.m.; two El Al flights were diverted. The Golan Regional Council instructed residents of the Golan Heights to remain in their shelters. Yoav Gallant declared an "emergency situation" for two days. Representatives of the United States were monitoring the situation. On 8 September, special forces from the Shaldag Unit raided and destroyed an Iranian rocket manufacturing facility beneath a branch of the Syrian Scientific Studies and Research Center in Masyaf, which was used to supply Hezbollah with precision rockets. On 16 September, the Security Cabinet of Israel approved a new war aim of returning evacuated residents to the north of Israel, adding to the goals of destroying Hamas and liberating the hostages.
Another strategy for site-specific amine conjugation to proteins is to replace lysine residues with arginine residues (LDVs). If all lysines are depleted then the only remaining free amine is at the amino terminus (N-terminus) of the protein. In the case where the protein is an antibody Fc domain, a recombinant LDV Fc can still be purified using protein A. LDV Fc proteins fused with short peptide targeting sequences can be used to deliver conjugated payloads, including nanoparticles, to specific cell surface proteins. The majority of ADCs under development or in clinical trials are for oncological and hematological indications. This is primarily driven by the inventory of monoclonal antibodies, which target various types of cancer. However, some developers are looking to expand the application to other important disease areas.
Valence 3 is dominant in all subsequent elements up to lawrencium (with the exception of nobelium). Curium can be tetravalent in solids (fluoride, dioxide). Berkelium, along with a valence of +3, also shows the valence of +4, more stable than that of curium; the valence 4 is observed in solid fluoride and dioxide. The stability of Bk4+ in aqueous solution is close to that of Ce4+. Only valence 3 was observed for californium, einsteinium and fermium. The divalent state is proven for mendelevium and nobelium, and in nobelium it is more stable than the trivalent state. Lawrencium shows valence 3 both in solutions and solids. The redox potential
Sources: en.wikipedia.org
Saakashvili wrote: "And above all, it is a war over the kind of Europe our children will live in." Saakashvili further wrote on 14 August that Russia felt threatened by Georgia's desire to pursue freedom and the world "cannot allow Georgia to become the first victim of a new world order as imagined by Moscow." On 24 August 2008, Georgian president Mikheil Saakashvili made a televised appearance. He remembered his interactions with both Vladimir Putin and Dmitry Medvedev. Saakashvili said that Putin had told him in the aftermath of the 2004 Adjara crisis: "Now remember, in Adjara we did not intervene, but you won't have any gifts from us in South Ossetia or Abkhazia." Saakashvili suggested that Russia was planning the invasion of Georgia since 2007. He said that although there were casualties among the Georgian forces on late 7 August 2008 and the Georgian defense minister was asking him to respond with artillery, his position was that Georgia "could not open fire whatever happened". Saakashvili also said that the Russian army had moved into South Ossetia before 8 August 2008 and Georgian pilots observed that "whole area [near the Roki Tunnel] was full of Russian military" on the morning of 8 August which could not be deployed "in a matter of hours; this is unreal." He criticized the West's inability to detect this movement via the satellites.
== Heparan sulfate analogues == Several Heparan sulfate analogues (also known as ReGeneraTing Agents, RGTA) have been developed from a poly glucose backbone. One named OTR4120 is a 85KD biopolymer and used for topical or ophthalmological application and marketed under the name CACIPLIQ20 or CACICOL20, respectively. Heparan sulfate analogues will occupy the free heparan sulfate binding sites on ECM macromolecules like collagen, fibronectin and laminin that become available following heparan sulfate degradation. In many characteristics heparan sulfate analogues are similar to the natural heparan sulfate. The most important difference is their resistance to enzymatic degradation. The resistance of RGTA is caused by the coupling of the subunits internal bond of the molecules. The β1-4 oxygen-linked binding of the subunits of heparan sulfate is prone to enzymatic cleavage whereas the α1-6 carbon-carbon binding of the subunits of RGTA are resistant to cleavage by all known mammalian glycanases and heparanases. This way RGTA can recreate a scaffold with the ECM proteins and will reposition GFs back into the matrix where they can re-unfold their natural action in wound repair. This way heparan sulfate analogues may contribute to chronic wound healing as will be discussed later on.
General Secretary Gorbachev, if you seek peace, if you seek prosperity for the Soviet Union, Central and South-East Europe, if you seek liberalization, come here to this gate; Mr. Gorbachev, open this gate. Mr. Gorbachev, tear down this wall! While aging Eastern European communist elites clung to "normalization," Mikhail Gorbachev exposed the stagnation at the heart of the Soviet Union's Communist Party. Assuming the post of General Secretary, he sought to reorder Soviet priorities in response to deepening structural decay: an economy largely unreformed since Stalin, paralyzed by central planning, and incapable of integrating the technological transformations reshaping the West. The result was a widening gap in living standards, particularly when contrasted against Western Europe and the United States. Facing declining revenues due to falling oil prices and rising expenditures related to the arms race and the command economy, the Soviet Union was forced during the 1980s to take on significant amounts of debt from the Western banking sector. Environmental historian J. R. McNeill notes that the Soviet state's clumsy efforts to conceal the 1986 Chernobyl accident in Ukraine—itself partly a product of Cold War secrecy imperatives—mobilized public opinion against the authorities and catalyzed the broader environmental agitation that spread across the USSR in the era's final years, marking an early instance of civic activism operating openly under glasnost. The socio-political effects of the Chernobyl debacle simultaneously increased public support for Gorbachev's own reforms.
Sources: en.wikipedia.org
Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.
Small short-term human trials examined metabolic markers such as lipids and glucose. The trials did not continue after rodent cancer findings, so long-term human safety is unknown.
Controlled human trials have not established a performance benefit. Anecdotal reports exist, but they are not reliable evidence.
Legal status varies by country. It is not approved as a medicine, and it is prohibited in sport. Some jurisdictions restrict import, sale, or possession.